✦ LIBER ✦

134 Adjuvant HDR brachytherapy in patients with recurrent advanced head and neck squamous cell carcinoma (SCC)

Book ID: 119516674
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 137 KB
Volume: 75
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(05)80134-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of surgical resection and HD

Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas

✍ Franziska Schiefke; Guido Hildebrandt; Stefan Pohlmann; Frank Heinicke; Alexande 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 641 KB

Survival in patients with recurrent squa

Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy

✍ Mario Airoldi; Antonella De Stefani; Sara Marchionatti; Fulvia Pedani; Pietro Ga 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Background We have shown that rIL‐2 administration in recurrent head and neck cancers induces a tumor‐specific T‐lymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5‐fluorouracil. Long‐term results

Paclitaxel and cisplatin in patients wit

Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma

✍ Vincenzo Adamo; Giuseppa Ferraro; Stefano Pergolizzi; Concetta Sergi; Agata Laud 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Racial Disparities in Patients With Head

Racial Disparities in Patients With Head and Neck Squamous Cell Carcinoma

✍ Christine G. Gourin; Robert H. Podolsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Efficacy of neck treatment in patients w

Efficacy of neck treatment in patients with head and neck squamous cell carcinoma

✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the